Treatment Without ADT Delays Initiation of Systemic Therapy in Prostate Cancer
MONDAY, Nov. 21, 2022 (HealthDay News) — For prostate cancer patients with a solitary oligometastatic lesion, metastasis-directed therapy without androgen deprivation therapy (ADT) can delay initiation of systemic therapy, according to a study publis…
Learn MoreVaginal Progesterone Not Tied to Reduction in Recurrent Preterm Birth
TUESDAY, Nov. 8, 2022 (HealthDay News) — Use of vaginal progesterone is not associated with a reduction in recurrent preterm birth, according to a study published online Oct. 31 in JAMA Network Open.David B. Nelson, M.D., from the University of Texas…
Learn MoreRace May Impact Satisfaction With Hormone Therapy for Menopause Symptoms
TUESDAY, Nov. 1, 2022 (HealthDay News) — Black and White women report different preferences for treatment for menopause symptoms, according to a study published Oct. 18 in Menopause.Monica Christmas, M.D., from the University of Chicago, and colleagu…
Learn MoreTime-Restricted Eating Has No Impact on Sex Steroids in Women
THURSDAY, Oct. 27, 2022 (HealthDay News) — Sex steroid levels remain largely unchanged with short-term time-restricted eating (TRE) among women, according to a study published online Oct. 6 in Obesity.Faiza Kalam, Ph.D., from Northwestern University …
Learn MoreAlmost All Adolescents Who Begin Gender-Affirming Hormones Continue Into Adulthood: Study
FRIDAY, Oct. 21, 2022 (HealthDay News) — When young adolescents strongly identify with a gender that does not match their gender at birth, one option is to offer a reversible treatment that can delay the onset of puberty.If the desire to transition e…
Learn MoreMost Teens Continue Gender-Affirming Hormones Into Adulthood
FRIDAY, Oct. 21, 2022 (HealthDay News) — Most adolescents who start gender-affirming hormone treatment continue treatment into adulthood, according to a Dutch study published online Oct. 20 in The Lancet Child & Adolescent Health.Maria Anna Theodora …
Learn MoreHormonal, Metabolic Parameters of PCOS May Vary by Region
TUESDAY, Oct. 18, 2022 (HealthDay News) — Regional differences in hormonal and metabolic parameters among women with polycystic ovary syndrome (PCOS) in California and Alabama indicate potential environmental impacts on PCOS, according to a study pub…
Learn MoreNeoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer
THURSDAY, Sept. 22, 2022 (HealthDay News) — Neoadjuvant therapy with a novel hormonal agent prior to radical prostatectomy is associated with better outcomes for men with high-risk prostate cancer versus upfront radical prostatectomy, according to a …
Learn MoreResponse to Neoadjuvant Endocrine Therapy for Breast Cancer May Vary by Race
TUESDAY, Sept. 20, 2022 (HealthDay News) — The response to neoadjuvant endocrine therapy (NET) for hormone receptor-positive breast cancer (HR+BC) may vary by race, according to a study presented at the 15th AACR Conference on the Science of Cancer H…
Learn MoreLa terapia hormonal contra el cáncer de mama podría funcionar de forma distinta según la raza de la paciente
VIERNES, 16 de septiembre de 2022 (HealthDay News) — La raza de las mujeres con un cáncer de mama podría ayudar a predecir el éxito de la terapia hormonal administrada antes de la cirugía.En un nuevo estudio, los investigadores encontraron que las mu…
Learn More